II. Epidemiology

  1. Weakness affects 5% of adults oiver age 60 years old

III. History

  1. Onset
    1. Acute onset within hours to days should prompt urgent assessment
      1. See Acute Motor Weakness Causes (Emergent Bilateral Motor Weakness)
      2. Acute Unilateral Weakness (aside from focal weakness) should prompt emergent CVA Evaluation
  2. Distinguish weakness from Fatigue and Asthenia
    1. Asthenia is exhaustion without weakness
    2. Fatigue is inability to perform task repeatedly
    3. Weakness is inability to perform task initially
    4. Consider Frailty and Sarcopenia of advanced age
  3. Distinguish weakness from pain-related disuse (e.g. specific joint Osteoarthritis)
  4. Determine distribution
    1. Unilateral Weakness (typically neurologic, especially if sensory involvement)
      1. Cerebrovascular Accident (CVA, critical to exclude in acute cases)
      2. Mononeuropathy (focal Peripheral Neuropathy)
      3. Multiple Sclerosis
      4. Myasthenia Gravis
    2. Symmetric proximal weakness (e.g. rising from chair, climbing steps, raising arms overhead)
      1. Myopathy
        1. See Myopathy Causes (e.g. Polymyositis, Polymyalgia Rheumatica, Thyroid disease)
    3. Symmetric distal weakness (e.g. drops items, cannot open jars, foot drop)
      1. Polyneuropathy
      2. Guillain-Barre Syndrome (affects proximal muscles as well)
      3. Amyotrophic Lateral Sclerosis
      4. Myopathy less commonly effects distal muscles
        1. Statins, Alcohol may effect distal and proximal
        2. Inclusion body Myositis
        3. Myotonic dystrophy
  5. Contributing factors
    1. Medication history
      1. See Medication Causes of Myositis
    2. Substance use history
      1. Alcohol Abuse
      2. Cocaine Abuse
      3. Huffing (esp. Glue)
    3. Family History
      1. Genetic Muscular Dystrophy
      2. Disorders of metabolism

IV. Exam: Neurologic Exam

  1. Motor Strength
    1. Evaluate specific upper and lower extremity testing (e.g. ulnar, median and Radial Nerve function)
    2. Evaluate for symmetric versus asymmetric weakness
    3. Upper Motor Neuron Lesion (everything is UP - tone, reflexes, toes)
    4. Lower Motor Neuron Lesion (everything is DOWN - tone, reflexes, toes)
  2. Sensory Exam
    1. Evaluate for dermatomal distribution of sensory loss
  3. Deep Tendon Reflexes
    1. Hyperreflexia (Upper Motor Neuron Lesion, Hyperthyroidism, Hypercalcemia)
    2. Hyporeflexia (Lower Motor Neuron Lesion, Hypothyroidism)
  4. Cranial Nerve Exam
    1. Ptosis and Diplopia may suggest Myasthenia Gravis
  5. Evaluate for Sarcopenia and Frailty
    1. Grip strength
    2. Get Up and Go Test

V. Exam: General

  1. Dermatomyositis changes (e.g. heliotrope rash, gottron Papules)
  2. Cushing's Disease changes (Obesity, Hypertension, Hirsutism, abdominal striae)
  3. Thyroid changes (e.g. Goiter)

VI. Evaluation

  1. Is motor weakness NOT objectively identified on exam?
    1. Conside Asthenia (exhaustion without weakness)
    2. Consider Fatigue (inability to perform task repeatedly)
    3. Consider Frailty and Sarcopenia of advanced age
    4. Consider Dyspnea
  2. Upper Motor Neuron Lesion (muscle group weakness without atrophy, hyperreflexia)?
    1. Acute Onset
      1. Emergency evaluation for Cerebrovascular Accident head imaging
    2. Subacute Onset
      1. Evaluate with head imaging for CNS Lesion, Spinal Cord Syndrome, Multiple Sclerosis
  3. Upper Motor Neuron Lesion AND Lower Motor Neuron Lesion
    1. Evaluate for Amyotrophic Lateral Sclerosis (Neurology, Electromyogram, Nerve Conduction Studies)
  4. Lower Motor Neuron Lesion (Flaccid Paralysis with muscle atrophy, fasciculations and hyporeflexia) OR non-specific
    1. Weakness is affected by repetition
      1. Weakness worsens with repetition: Myasthenia Gravis (associated with Ptosis, Diplopia, Dysarthria, Dysphagia)
        1. Anti-acetylcholine receptor Antibody positive
        2. Neurology Consultation and (if labs negative, Electromyogram, Nerve Conduction Studies)
      2. Weakness improves with repetition: Lambert-Eaton Syndrome
        1. Voltage-Gated Calcium Channel Antibody positive
        2. Neurology Consultation and (if labs negative, Electromyogram, Nerve Conduction Studies)
    2. Sensory deficit
      1. Suggests Neuropathy (e.g. Diabetic Neuropathy)
      2. Evaluate with Serum Glucose, Vitamin B12
      3. Evaluate for Substance Abuse and toxin exposures
      4. Consider Neurology Consultation and Electromyogram, Nerve Conduction Studies
      5. Muscle biopsy may be considered in unclear cases
    3. Asymmetric weakness
      1. Consider Compressive Neuropathy, Parsonage-Turner Syndrome
      2. Consider Neurology Consultation and Electromyogram, Nerve Conduction Studies
      3. Consider MRI Brain
    4. Symmetric weakness
      1. Painful
        1. Consider Medication Causes of Myositis (esp. Statins and Quinolones)
        2. Consider Rhabdomyolysis and inflammatory Myopathy
        3. Evaluate with CK, myoglobin, ESR, CRP and consider ANA
        4. Consider Rheumatology Consultation
        5. Consider Neurology Consultation
        6. Muscle biopsy may be considered in unclear cases
      2. Not significantly painful
        1. See Muscle Weakness Causes
        2. Broad-based laboratory evaluation (e.g. chem8, TSH, CK, cortisol)
        3. Careful history including Substance Abuse, toxin exposures and Family History
        4. Consider Neurology Consultation and Electromyogram, Nerve Conduction Studies
        5. Muscle biopsy may be considered in unclear cases

VII. Differential Diagnosis

  1. See Muscle Weakness Causes
  2. See Acute Motor Weakness Causes (Emergent Bilateral Motor Weakness)
  3. Consider Frailty and Sarcopenia of advanced age
  4. Consider primary neurologic disorders
    1. See Neuropathy
    2. Upper Motor Neuron Lesion (e.g. CVA, Multiple Sclerosis)
    3. Lower Motor Neuron Lesion (e.g. Guillain-Barre Syndrome, Compressive Neuropathy)
  5. Consider primary muscle disorders
    1. Myotonia (muscle stiffness)
    2. Myositis (e.g. Polymyositis, Dermatomyositis, Inclusion body Myositis)
    3. Muscular Dystrophy (e.g. Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy, Myotonic Dystrophy)
  6. Consider toxic and metabolic causes
    1. See Toxic Myopathy (Medication Causes of Myositis)
    2. Electrolyte disturbance (e.g. Hypokalemia)
    3. Endocrine disorder (e.g. Hyperthyroidism or Hypothyroidism)

VIII. Labs: As Indicated

  1. See Neuropathy
  2. Myopathy (see also Polymyositis)
    1. Creatine Kinase (CPK)
    2. Erythrocyte Sedimentation Rate
    3. C-Reactive Protein
    4. Serum chemistry (e.g. Chem 8)
      1. Electrolytes Glucose, calcium, Magnesium, phosphate
    5. Thyroid Stimulating Hormone (TSH)
    6. Urinalysis
      1. Myoglobinuria
    7. Vitamin B12
  3. Other tests as indicated
    1. 24-hour urine cortisol
    2. Growth Hormone
    3. Antinuclear Antibody
    4. HIV Test
    5. Lyme Disease Test
    6. West Nile Virus Test
    7. Dengue Fever Test
    8. Lumbar Puncture
    9. Anti-acetylcholine receptor Antibody (Myasthenia Gravis)
    10. Weakness improves with repetition:

IX. Imaging: As Indicated

  1. MRI Brain

X. Diagnostics: As Indicated

  1. Electromyogram
  2. Nerve Conduction Studies
  3. Muscle Biopsy
    1. Reserved for specific Myopathy cases (objective weakness and positive testing), typically by neurology recommendation
    2. Biopsy performed by surgical consultant of muscle with mild to moderate weakness
    3. Avoid biopsy of muscles with severe weakness (nondiagnostic results with fat and fibrosis change)

Images: Related links to external sites (from Bing)

Related Studies

Ontology: Muscle Weakness (C0151786)

Definition (MSHCZE) Neurčitý pocit ochablosti, únavy nebo vyčerpanosti, který může být atributem slabosti různých svalů. Slabost je charakterizována jako subakutní nebo chronická, často jako zhoršující se a je projevem mnoha svalových a neurosvalových nemocí. (In Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251) R
Definition (NCI) A reduction in the strength of one or more muscles.
Definition (MSH) A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
Concepts Sign or Symptom (T184)
MSH D018908
SnomedCT 26544005
English Muscle Weaknesses, Muscular Weakness, Muscular Weaknesses, Weakness, Muscle, Weakness, Muscular, Weaknesses, Muscle, Weaknesses, Muscular, Decreased muscle strength, Diminished muscle strength, Muscle Weakness, muscle weakness (symptom), muscle weakness, Muscle weakness NOS, Weakness muscle, Muscle Weakness [Disease/Finding], decreased muscle strength, muscle weaknesses, muscular weakness, Weakness;muscle(s), WEAKNESS, MUSCULAR, MUSCLE WEAKNESS, Muscular weakness, Muscle weakness, Muscle strength reduced, Muscle weakness (finding), muscle; weakness
Spanish DEBILIDAD MUSCULAR, Debilidad muscular, Debilidad muscular NEOM, debilidad muscular, debilidad muscular (hallazgo), paresia, paresia (hallazgo), fuerza muscular disminuida, Pérdida de fuerza muscular, Debilidad Muscular
Dutch spier zwakte, spierzwakte NAO, zwakte van spier, spier; zwak, spierzwakte, Spierzwakte, Zwakte, spier-
French Faiblesse de muscle, Faiblesse musculaire SAI, FAIBLESSE MUSCULAIRE, Faiblesse musculaire, Faiblesse du muscle
German Muskelschwaechen, Schwaeche Muskel, Muskelschwaeche NNB, MUSKELSCHWAECHE, Muskelschwaeche, Muskelschwäche
Italian Debolezza muscolare NAS, Debolezza muscolare
Portuguese Fraqueza do músculo, Paresia NE, FRAQUEZA MUSCULAR, Fraqueza muscular, Debilidade Muscular
Japanese 筋力低下NOS, キンリョクテイカNOS, キンリョクテイカ, 筋力低下
Swedish Muskelsvaghet
Czech svaly - slabost, Svalová slabost, Slabost svalu, Svalová slabost NOS
Finnish Lihasheikkous
Russian MYSHECHNAIA SLABOST', МЫШЕЧНАЯ СЛАБОСТЬ
Polish Osłabienie mięśni, Słabość mięśni
Hungarian Izomgyengeség k.m.n., Izomgyengeség
Norwegian Muskelsvakhet

Ontology: Generalized muscle weakness (C0746674)

Definition (NCI_CTCAE) A disorder characterized by a reduction in the strength of muscles in multiple anatomic sites.
Definition (NCI) A reduction in the strength of muscles in multiple anatomic sites.
Concepts Sign or Symptom (T184)
ICD9 728.87
ICD10 M62.81
Dutch gegeneraliseerde spierzwakte
French Faiblesse musculaire généralisée
German generalisierte Muskelschwaeche
Italian Debolezza muscolare diffusa, Debolezza muscolare generalizzata
Portuguese Fraqueza muscular generalizada
Spanish Debilidad muscular generalizada
Japanese 全身筋力低下, ゼンシンキンリョクテイカ
English Muscle weakness, generalized, generalized muscle weakness (symptom), generalized muscle weakness, Generalized Muscle Weakness, Muscle weakness-general, Muscle weakness (generalized), Generalised muscle weakness, Generalized muscle weakness
Czech Generalizovaná svalová slabost
Hungarian Generalizált izomgyengeség